Kater AP, Jiang Y, Chyla B, Seymour JF. Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab. Haematologica [Internet]. 2020Jul.1 [cited 2026Nov.15];105(7):e382-e383. Available from: https://haematologica.org/article/view/9966